Results 11 to 20 of about 33,583 (261)
Biomedicines, 2023 Erythropoiesis-stimulating agents improve the NYHA functional class and decrease the hospital readmission rates for heart failure; however, little is known about the influence of continuous erythropoietin receptor activator (CERA) on the heart. Therefore,
Akira Sezai +4 more
doaj +1 more source
Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
Journal of Cardiovascular Development and Disease, 2022 Cardiotoxicity is a significant complication of chemotherapeutic agents in cancer patients. Cardiovascular incidents including LV dysfunction, heart failure (HF), severe arrhythmias, arterial hypertension, and death are associated with high morbidity and
Christos Kourek +6 more
doaj +1 more source
Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease [PDF]
American Journal of Physiology-Renal Physiology, 2018 While sodium-glucose cotransporter-2 (SGLT2) inhibitors have been used for the routine management of type 2 diabetes for several years, it is perhaps their natriuretic effects that are most important clinically. This natriuresis activates tubuloglomerular feedback, resulting in reduced glomerular hypertension and proteinuria, leading to renal ...
David León Jiménez +4 more
openaire +3 more sources
Natriuretic Peptides: The Case of Prostate Cancer
Molecules, 2017 Cardiac natriuretic peptides have long been known to act as main players in the homeostatic control of blood pressure, salt and water balance. However, in the last few decades, new properties have been ascribed to these hormones.
Letizia Mezzasoma +3 more
doaj +1 more source
Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus
Diabetology & Metabolic Syndrome, 2022 Background Dipeptidyl peptidase-4 inhibitors (DPP-4i) decrease glucose levels by regulating incretin peptides in type 2 diabetes mellitus (T2DM). This study aimed to determine the modulatory effect of DPP-4i on brain natriuretic peptide (BNP) and N ...
Liying Mu +5 more
doaj +1 more source
New Cardioprotective Agent K201 Is Natriuretic and Glomerular Filtration Rate Enhancing [PDF]
Circulation, 2006 Background— K201 (JTV519) is a newly developed 1,4-benzothiazepine drug with antiarrhythmic and cardioprotective properties. It functions via stabilization of the ryanodine receptor–calcium release channel in the heart (RyR2).
Ondrej, Lisy, John C, Burnett
openaire +2 more sources
Vascular Health and Risk Management, 2022 Elizabeth do Espirito Santo Cestario,1,* Jose Fernando Vilela-Martin,1,* Luciana Neves Cosenso-Martin,1 Tatiane Azevedo Rubio,1 Jessica Rodrigues Roma Uyemura,1 Valquiria da Silva Lopes,1 Letícia Aparecida Barufi Fernandes,1 Lucia Helena Bonalume
Cestario EDES +9 more
doaj
Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE
Cardiovascular Diabetology, 2020 There are many glucose-lowering agents used in patients with heart failure, showing mixed results, this study was conducted to determine the effect of liraglutide, a glucagon-like peptide-1 analogue, on the treatment of patients with heart failure ...
Bo Liang, Ning Gu
doaj +1 more source
Sodium channel blockers are vasodilator as well as natriuretic and diuretic agents. [PDF]
Hypertension, 1985 Amiloride (100-400 micrograms) injected intra-arterially into the dog forelimb perfused at constant flow produced a prompt but transient dose-dependent decrease in perfusion pressure. Intravenous injection lowered systemic arterial pressure, but effects were small and transient except in doses exceeding 10 mg.
F J, Haddy +4 more
openaire +2 more sources
Frontiers in Oncology, 2014 Multi-modality cancer treatments that include chemotherapy, radiation therapy, and targeted agents are highly effective therapies. Their use, especially in combination, is limited by the risk of significant cardiac toxicity.
Sibo eTian +6 more
doaj +1 more source